References
- Reisine T, Pasternak G. Opioid analgesics and antagonists. Goodman and Gilman's Pharmacologic Basis of Therapeutics, 9th edition, J G Hardman, L E Limbird, P B Molinoff, R W Ruddon, A G Gilman. McGraw-Hill, Toronto, OntarioCanada 1996; 549–51
- Marx J A, Hockberger R S, Walls R M. Rosen's Emergency Medicine, 5th Edition. Mosby, St. Louis, MO 2002; 2184
- Popa V, Rients B. The effect of inhaled naloxone on resting bronchial tone and exercise-induced asthma. Am Rev Respir Dis 1989; 139: 702–9
- Wanger K, Brough L, Macmillan I, et al. Intravenous vs subcutaneous naloxone for out-of-hospital management of presumed opioid overdose. Acad Emerg Med 1998; 5: 293–9
- Barton E D, Ramos J, Colwell C, et al. Intranasal administration of naloxone by paramedics. Prehosp Emerg Care 2002; 6: 54–8
- Kelly A M, Koutsogiannis Z. Intranasal naloxone for life threatening opioid toxicity. Emerg Med J 2002; 19: 375
- Kelley A M, Kerr D, Dietz P, et al. Randomized trial of intranasal versus intramuscular naloxone in prehospital treatment for suspected opioid overdose. MJA 2005; 182(1)24–7
- Pontiroli A E, Calderara A, Pajetta E, et al. Intranasal glucagon for remedy of hypoglycemia. Studies in healthy subjects and type 1 diabetic patients. Diabetes Care 1989; 12: 604–8
- Hochreiter M C, Barton L L. Epidemiology of needlestick injury in emergency medical service personnel. J Emerg Med 1988; 6(1)9–12
- National Center for Infectious Diseases, Centers for Disease Control and Prevention. Exposure to blood: what healthcare personnel need to know. July, 2003, Available at: http://www.cdc.gov/ncidod/dhqp/pdf/bbp/Exp_to_Blood.pdf Accessed July 28, 2009